ENDV (Endonovo Therapeutics) 3-Year Dividend Growth Rate: 0.00% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Endonovo Therapeutics 3-Year Dividend Growth Rate?

Endonovo Therapeutics ENDV 3-Year Dividend Growth Rate is 0.00% as of Jun. 2025.

Endonovo Therapeutics's Dividends per Share for the three months ended in Jun. 2025 was $0.00.

The historical rank and industry rank for Endonovo Therapeutics's 3-Year Dividend Growth Rate or its related term are showing as below:

ENDV's 3-Year Dividend Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 5.2
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Endonovo Therapeutics's Dividend Payout Ratio for the three months ended in Jun. 2025 was 0.00. As of today, Endonovo Therapeutics's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Endonovo Therapeutics  (OTCPK:ENDV) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Endonovo Therapeutics's Dividend Payout Ratio for the quarter that ended in Jun. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2025 )/ EPS without NRI (Q: Jun. 2025 )
=0/ -0
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics 3-Year Dividend Growth Rate Related Terms>

ENDV vs RGBP, SIGY, CNBX: 3-Year Dividend Growth Rate Comparison

For the Biotechnology subindustry, Endonovo Therapeutics's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endonovo Therapeutics 3-Year Dividend Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Endonovo Therapeutics's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Endonovo Therapeutics's 3-Year Dividend Growth Rate falls into.


Endonovo Therapeutics 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Dividend Growth Rate of 0.00% mean?
Endonovo Therapeutics (ENDV) has a 3-Year Dividend Growth Rate of 0.00% as of Jun. 2025. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Endonovo Therapeutics and its competitors.
Is Endonovo Therapeutics' 3-Year Dividend Growth Rate too high?
Endonovo Therapeutics' current 3-Year Dividend Growth Rate is 0.00%.
How does Endonovo Therapeutics' 3-Year Dividend Growth Rate compare to RGBP and SIGY?
Endonovo Therapeutics' 3-Year Dividend Growth Rate of 0.00% can be compared against companies in the Biotechnology industry. The industry median 3-Year Dividend Growth Rate is 5.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Biotechnology company?
The median 3-Year Dividend Growth Rate among Biotechnology companies is 5.20, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Endonovo Therapeutics and its competitors. For the Biotechnology industry, the median 3-Year Dividend Growth Rate is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Endonovo Therapeutics's current 3-Year Dividend Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current 3-Year Dividend Growth Rate of 0.00%. The current 3-Year Dividend Growth Rate is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current 3-Year Dividend Growth Rate is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.